vVARDIS Holding AG has priced its initial public offering of 9,722,223 Class A ordinary shares at $18.00 per share, according to the company. The shares are expected to begin trading on the New York Stock Exchange under the symbol "VVVV" on November 13, 2026.
The Zug, Switzerland-based dental med-tech company has granted underwriters a 30-day option to buy up to an additional 1,458,333 Class A ordinary shares at the IPO price to cover over-allotments. The offering is expected to close on or about November 16, 2026, subject to customary closing conditions.
Goldman Sachs & Co. LLC and J.P. Morgan are joint bookrunning managers. William Blair, UBS Investment Bank, and Deutsche Bank Securities are bookrunners.
The U.S. Securities and Exchange Commission declared the Form F-1 registration statement effective on November 12, 2026. According to the company's press release, vVARDIS markets dental products under the Curodont brand.